Synthesis, Characterization, Antitumor Activity of Pluronic Mimicking Copolymer Micelles Conjugated with Doxorubicin via Acid-Cleavable Linkage
- 29 December 2007
- journal article
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 19 (2), 525-531
- https://doi.org/10.1021/bc700382z
Abstract
Pluronic mimicking poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) (PEO-PPO-PEO) triblock copolymer having multiple hydroxyl groups in the PPO middle segment (core-functionalized Pluronic: CF-PLU) was synthesized for conjugation of doxorubicin (DOX). DOX was conjugated on the multiple hydroxyl groups of CF-PLU via an acid-labile hydrazone linkage (CF-PLU-DOX). In aqueous solution, CF-PLU-DOX copolymers self-assembled to form a core/shell-type micelle structure consisting of a hydrophobic DOX-conjugated PPO core and a hydrophilic PEO shell layer. The conjugated DOX from CF-PLU-DOX micelles was released out more rapidly at pH 5 than pH 7.4, indicating that the hydrazone linkage was cleaved under acidic condition. CF-PLU-DOX micelles exhibited greatly enhanced cytotoxicity for MCF-7 human breast cancer cells compared to naked DOX, while CF-PLU copolymer itself showed extremely low cytotoxicity. Flow cytometry analysis revealed that the extent of cellular uptake for CF-PLU-DOX micelles was greater than free DOX. Confocal image analysis also showed that CF-PLU-DOX micelles had a quite different intracellular distribution profile from free DOX. CF-PLU-DOX micelles were mainly distributed in the cytoplasm, endosomal/lysosomal vesicles, and nucleus, while free DOX was localized mainly within the nucleus, suggesting that CF-PLU-DOX micellar formulation might be advantageously used for overcoming the multidrug resistance (MDR) effect, which gradually develops in many tumor cells during repeated drug administration.Keywords
This publication has 31 references indexed in Scilit:
- Structural optimization of a “smart” doxorubicin–polypeptide conjugate for thermally targeted delivery to solid tumorsJournal of Controlled Release, 2006
- Alteration of Genomic Responses to Doxorubicin and Prevention of MDR in Breast Cancer Cells by a Polymer Excipient: Pluronic P85Molecular Pharmaceutics, 2005
- Determination of Doxorubicin Levels in Whole Tumor and Tumor Nuclei in Murine Breast Cancer TumorsClinical Cancer Research, 2005
- Polymeric micellar pH-sensitive drug delivery system for doxorubicinJournal of Controlled Release, 2005
- Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumorJournal of Controlled Release, 2005
- Preparation and Biological Characterization of Polymeric Micelle Drug Carriers with Intracellular pH-Triggered Drug Release Property: Tumor Permeability, Controlled Subcellular Drug Distribution, and Enhanced in Vivo Antitumor EfficacyBioconjugate Chemistry, 2004
- Cell-Specific Delivery of a Chemotherapeutic to Lung Cancer CellsJournal of the American Chemical Society, 2004
- Folate-receptor-targeted delivery of doxorubicin nano-aggregates stabilized by doxorubicin–PEG–folate conjugateJournal of Controlled Release, 2004
- Drug delivery in pluronic micelles: effect of high-frequency ultrasound on drug release from micelles and intracellular uptakeJournal of Controlled Release, 2002
- New HPMA copolymers containing doxorubicin bound via pH-sensitive linkage: synthesis and preliminary in vitro and in vivo biological propertiesJournal of Controlled Release, 2001